Search by Drug Name or NDC

    NDC 00338-3814-24 Clindamycin phosphate 900 mg/50mL Details

    Clindamycin phosphate 900 mg/50mL

    Clindamycin phosphate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is CLINDAMYCIN PHOSPHATE.

    Product Information

    NDC 00338-3814
    Product ID 0338-3814_e4c83966-9baa-4b5b-a365-52e4da1a174a
    Associated GPIs 16220020312040
    GCN Sequence Number 015999
    GCN Sequence Number Description clindamycin phosphate/D5W PIGGYBACK 900MG/50ML INTRAVEN
    HIC3 W1K
    HIC3 Description LINCOSAMIDE ANTIBIOTICS
    GCN 40822
    HICL Sequence Number 004704
    HICL Sequence Number Description CLINDAMYCIN PHOSPHATE/DEXTROSE 5 % IN WATER
    Brand/Generic Generic
    Proprietary Name Clindamycin phosphate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clindamycin phosphate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 900
    Active Ingredient Units mg/50mL
    Substance Name CLINDAMYCIN PHOSPHATE
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208084
    Listing Certified Through 2024-12-31

    Package

    NDC 00338-3814-24 (00338381424)

    NDC Package Code 0338-3814-24
    Billing NDC 00338381424
    Package 24 BAG in 1 CARTON (0338-3814-24) / 50 mL in 1 BAG (0338-3814-50)
    Marketing Start Date 2017-06-28
    NDC Exclude Flag N
    Pricing Information N/A